Company intelligence / Profile preview

Inwell Biosciences

Ownership: Private
Development stage: Commercial

Overview

Inwell Biosciences offers professional-grade dietary supplements designed by healthcare practitioners for use by other practitioners. Their products focus on holistic well-being and target a range of body functions including immune defense, gut health, heart/metabolism, hormone/adrenal balance, cognitive/mood support. All products are manufactured in cGMP-compliant facilities and sold exclusively through healthcare professionals.

Therapeutic areas: EndocrinologyImmunologyOtherPsychiatryGastroenterologyCardiovascular
Modalities: Small moleculeProteinPeptidesBiologicNutraceuticals
Industry: Food & Nutrition

Drug pipeline

4 assets

Mito Multi

Commercial

3 more assets in the full pipeline.

Request access →

Partnerships

Forum Health clinics/practitioners network

Beyond the preview

Go deeper on Inwell Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inwell Biosciences.

Explore the full profile